Dr. Galati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6560 Fannin St
Suite 2050
Houston, TX 77030Phone+1 713-794-0700Fax+1 713-794-0610
Summary
Education & Training
- University of Nebraska Medical Center College of MedicineFellowship, Transplant Hepatology, 1991 - 1994
- SUNY Downstate Health Sciences UniversityChief Residency, Internal Medicine, 1990 - 1991
- SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1988 - 1990
- SUNY Downstate Health Sciences UniversityInternship, Internal Medicine, 1987 - 1988
- St. George's University School of MedicineClass of 1987
- Syracuse UniversityBS, Biology, 1978 - 1981
Certifications & Licensure
- TX State Medical License 1995 - 2025
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Fellow American Association for the Study of Liver Diseases, 2015
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- Join now to see all
Clinical Trials
- Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection Start of enrollment: 2013 Jun 01
- Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing Start of enrollment: 2014 Feb 01
- Study of Oral Treatments for Hepatitis C Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial.Benjamin J Bruno, Joshua C Weavil, Jonathan Ogle, Nachiappan Chidambaram, Elizabeth J Carey
Hepatology. 2024-11-08 - 2 citationsSuccessful Treatment of Invasive Mucormycosis in Orthotopic Liver Transplant Population.Taryn A Eubank, Constance M Mobley, Mozhgon Moaddab, Mark J Hobeika, Melissa O'Neal
Case Reports in Transplantation. 2021-01-01 - 20 citationsOutcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience.David W. Victor, Howard Paul Monsour, Maha Boktour, Keri E. Lunsford, Julius Balogh
Transplantation. 2020-01-01
Press Mentions
- 8 Resources That Can Help You Afford Hepatitis C TreatmentJanuary 30th, 2023
- In Cirrhosis, Less Activity Equals Worse OutcomesMarch 23rd, 2022
- Sunrise Rotary to Host Conference with Guest SpeakerApril 28th, 2021
- Join now to see all
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: